NYSE$CYH

Community Health Systems Inc · Q1 2020 earnings

Q1 2020 earnings · · Investor relations

Briefing

Community Health Systems' financial performance was impacted by COVID-19, resulting in decreased revenues and increased expenses, but net income was positive due to tax valuation allowance.

Community Health Systems reported a decrease in net operating revenues and an increase in expenses due to the COVID-19 pandemic. However, the company reported a net income attributable to common stockholders of $18 million, or $0.15 per share, due to a change in tax valuation allowance.

  • Net operating revenues totaled $3.025 billion.
  • Net income attributable to common stockholders was $18 million, or $0.15 per share.
  • Adjusted EBITDA was $309 million.
  • Net cash provided by operating activities was $57 million.

Headline financials

Total Revenue

$3.03B

Previous: $3.38B-10.4%
EPS (adj)

-$1.59

Previous: -$0.53-200.0%
Adjusted EBITDA

$309M

Previous: $391M-21.0%
Capital Expenditures

-$99M

Previous: -$121M+18.2%
Free Cash Flow

-$81M

Previous: -$239M+66.1%
Net Income

$18M

Previous: -$118M+115.3%
Operating Income

$110M

Previous: $189M-41.8%
Gross Profit

$2.53B

Previous: $2.82B-10.3%
Cash & Equivalents

$246M

Previous: $277M-11.2%
Total Assets

$15.4B

Previous: $16.3B-5.3%
Stock-Based Comp

$2M

Previous: $3M-33.3%

Revenue & EPS history

CHS · Revenue · Quarterly

$3.03B

Q1 2020-10.4%vs Q1 2019
Beat estimate in 9 of 16 quarters(56%)
ActualEstimate

Forward guidance

The company withdrew its 2020 financial guidance previously issued in its earnings release dated February 19, 2020 and is not providing further guidance in this earnings release.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2020

Historical avgQ1 2020

+1.7%

Avg return

Earnings day

+3.6%

Avg return

5 days after

+2.4%

Avg return

30 days after

55%

38 / 69 earnings

Positive

+52.4%

Q4 2022

Best reaction

-41.0%

Q2 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.3%+6.3%+3.0%
Q4 2025+5.7%+4.5%-13.5%
Q3 2025+25.8%+29.1%-4.3%
Q2 2025+0.0%-0.7%+7.7%
Q1 2025+18.5%+11.1%+51.0%
Q4 2024+7.8%+9.9%-22.4%
Q3 2024-22.6%-25.3%-33.5%
Q2 2024+17.5%+27.9%+24.9%
Q1 2024+9.8%+11.1%+20.9%
Q4 2023-28.4%-27.7%-11.6%
Q3 2023-7.0%-18.0%+12.1%
Q2 2023+11.8%-8.4%-18.9%
Q1 2023-39.9%-42.3%-48.4%
Q4 2022+52.4%+56.3%-0.6%
Q3 2022+36.8%+35.4%+68.9%
Q2 2022-41.0%-39.6%-38.6%
Q1 2022-4.2%-19.1%-40.1%
Q4 2021-10.1%-21.3%-15.1%
Q3 2021+19.1%+28.9%+28.4%
Q2 2021-6.4%-8.3%-13.1%
Q1 2021+0.3%+15.2%+37.9%
Q4 2020-7.6%-9.3%+28.3%
Q3 2020+19.2%+30.3%+78.3%
Q2 2020+14.2%+26.4%+37.8%
Q1 2020-7.4%-22.9%-11.8%
Q4 2019+42.7%+27.8%-44.2%
Q3 2019-17.0%-30.4%-32.6%
Q2 2019+12.9%+25.8%+39.7%
Q1 2019-1.7%-4.0%-19.9%
Q4 2018+12.8%+21.4%+8.5%
Q3 2018-6.3%+20.0%+33.3%
Q2 2018+2.3%+9.5%+16.7%
Q1 2018+34.7%+26.5%+8.2%
Q4 2017-11.6%-15.0%-31.6%
Q3 2017-23.1%-26.6%-26.3%
Q2 2017-7.8%-8.8%+6.9%
Q1 2017+19.9%+11.7%+2.8%
Q4 2016+33.8%+33.6%+21.7%
Q3 2016+0.8%+4.9%+3.0%
Q2 2016-1.5%-0.5%-19.3%
Q1 2016-22.1%
Q4 2015-22.1%
Q3 2015-2.4%
Q2 2015+1.2%
Q1 2015-7.6%
Q4 2014+1.2%
Q3 2014-5.0%
Q2 2014-4.9%
Q1 2014-7.2%
Q4 2013+0.3%
Q3 2013-0.3%
Q2 2013+2.2%
Q1 2013+4.7%
Q4 2012+1.4%
Q3 2012+2.4%
Q2 2012-4.3%
Q1 2012+5.2%
Q4 2011+5.3%
Q3 2011-2.7%
Q2 2011-6.4%
Q1 2010-3.5%
Q1 2011+0.1%
Q4 2008+8.0%
Q4 2010+8.0%
Q3 2009+2.0%
Q3 2010+2.0%
Q4 2009+4.3%
Q2 2009+4.3%
Q2 2010+4.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro